论文部分内容阅读
[目的]观察血脂康胶囊治疗血脂异常疗效。[方法]使用随机平行对照方法,将70例门诊患者按随机数字表分为两组。对照组25例血脂康胶囊模拟剂,2粒/次,2次/d。治疗组45例血脂康胶囊,2粒/次,2次/d。连续治疗8周为1疗程。观测血脂水平TC(总胆固醇)、TG(甘油三脂)、HDL-C(高密度脂蛋白胆固醇)、LDL-C(低密度脂蛋白胆固醇):用药前2周、用药后当日、4周后及疗程结束后各检测1次。连续治疗2疗程,判定疗效。[结果]治疗组显效18例,有效20例,无效7例,总有效率84.44%。对照组显效2例,有效5例,无效18例,总有效率28.00%。治疗组疗效优于对照组(P<0.05)。血脂水平对照组治疗前后无明显差异(P>0.05);治疗组治疗前后有显著性差异(P<0.05)。[结论]血脂康胶囊治疗血脂异常效果显著,值得推广。
[Objective] To observe the therapeutic effect of Xuezhikang on dyslipidemia. [Methods] Using randomized parallel control method, 70 outpatients were divided into two groups according to random number table. Control group 25 Xuezhikang capsule simulant, 2 capsules / time, 2 times / d. Treatment group 45 Xuezhikang capsules, 2 capsules / time, 2 times / d. Continuous treatment for 8 weeks for a course of treatment. The levels of TC, TG, HDL-C and LDL-C were measured: 2 weeks before treatment, 4 days after treatment, And after the end of treatment each test 1. Continuous treatment of 2 courses to determine the efficacy. [Result] In the treatment group, 18 cases were markedly effective, 20 cases were effective and 7 cases were ineffective. The total effective rate was 84.44%. In the control group, 2 cases were markedly effective, 5 cases were effective, 18 cases were ineffective, and the total effective rate was 28.00%. The treatment group was better than the control group (P <0.05). There was no significant difference in the level of serum lipids between before and after treatment in the control group (P> 0.05). The treatment group had significant difference before and after treatment (P <0.05). [Conclusion] Xuezhikang capsule is effective in treating dyslipidemia and is worth promoting.